Additionally, KMT2D has been known to interact with the PAX-interacting protein 1 (PAXIP-1) as well as other transcription factors encoded by PAX2. These factors have a high rate of expression in the developing eye, which may also explain microphthalmia and eye developmental disorder in utero [136]. This evidence concerns the gene PAXIP1 and microphthalmia.